Aspirin, Vascular Disease and Cancer: 50 Years of Controversy and the Jury’s Still Out!
Journal Title: Open Access Journal of Oncology and Medicine - Year 2018, Vol 2, Issue 1
Abstract
The story of aspirin and vascular disease starts with John O Brien, a haematologist in Portsmouth in the 1960s, who reported that the ingestion of 150mg of aspirin substantially reduced the aggregation of platelets [1]. On the basis of this finding, and the assumption that the incidence of thrombosis would be reduced, O’Brien persuaded the UK Medical Research Council in 1968 to set up a randomised trial of aspirin [2]. Three hundred and three surgical patients in four UK hospitals were randomly given 600mg aspirin or a placebo once preoperatively and on five post-operative days. The outcome was deep vein thrombosis diagnosed by I125- labelled fibrinogen. The conclusion, written presumably by Austin Heady the statistician on the team, was: ‘aspirin administration has not even a marginal effect on the frequency of DVT’. This dismissal now appears rather confident in view of the later finding of clinically important reductions by aspirin in venous thrombosis and pulmonary embolism after surgery [3]. O Brien was convinced that venous thrombosis had been an inappropriate test of aspirin in the reduction of thrombosis but he failed to persuade MRC to conduct another trial. However, persuaded by work in the Welsh National School of Medicine in the 1960s on aspirin, platelet ’clumping’ and ‘infarctoid cardiopathy’,[4-6] Archie Cochrane agreed that a trial of aspirin and vascular mortality be set up in South Wales. 1,400 postmyocardial infarction patients agreed to be randomised to 325mg aspirin orally per day the dose and frequency suggested for the trial by O’Brien.
Authors and Affiliations
Peter Elwood
Keywords
Related Articles
- EP ID EP587892
- DOI 10.32474/OAJOM.2018.02.000126
- Views 69
- Downloads 0
Use of Umblical Cord Blood in the Management of Leukaemia
Leukaemia is a blood disorder caused by uncontrolled production and release of abnormal blasts cells in the bone marrow and in the circulation. Treatment of leukaemia has been a great challenge and many patients die. The...
Studies on Hybridization and Genetic Diversity in Cowpea (Vigna Unguiculata L)
Crossability of various accessions of cowpea on the basis of pollen development and fruit set was studied along with genetic diversity by SSR markers. There was a significant correlation between fruit set and percent via...
Quality of Life in Oncological Patient at the End of Life
Cancer is one of the diseases that have the greatest impact on the quality of life of its patients, either because of the real burden of the disease or because of all the myths involved in its diagnosis. The objective of...
Promising Role of Fractional Calculus in Biomedicine and Biophysics
The study of complex systems and investigation of their structural and dynamical properties have attracted considerable interests among scientists in general and physicists, biologists and medical researchers in particul...
Hydrogen Peroxide and Cancer
I’ll share an antidotal observation that may prove useful to cancer researchers. I studied hyper-ferritism and Ferric Chloride to see its possible link to schizophrenia. Those results are well published [1,2]. However, I...